Skip to content
healthcare.dev

Desvenlafaxine

NDC 10135-822, Desvenlafaxine, tablet, extended release, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-822
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204805
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-822 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DESVENLAFAXINE SUCCINATE100 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
10135-822-10101350822101000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-10)
10135-822-141013508221414 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-14)
10135-822-301013508223030 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-30)
10135-822-901013508229090 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-822-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/387cea91-6924-2a68-e063-6394a90a8f75

Use it

Look up 10135-822 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-822 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.